SML3592
GSK3179106
≥98% (HPLC)
Synonym(s):
2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C22H21F4N3O4
CAS Number:
Molecular Weight:
467.41
UNSPSC Code:
12352200
NACRES:
NA.21
Recommended Products
![2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/378/828/9834c930-f37e-4730-8e9c-00a587e5421d/640/9834c930-f37e-4730-8e9c-00a587e5421d.png)
Quality Level
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Biochem/physiol Actions
GSK3179106 is a potent and selective gut-restricted RET (Rearranged during transfection) kinase inhibitor. GSK3179106 attenuates abdominal contractions induced by colorectal distention in rat models.
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity
Journal of Pharmacology and Experimental Therapeutics, 368, 299-307 (2019)
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS
ACS Medicinal Chemistry Letters, 9, 623-628 (2018)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service